Pure Red-Cell Aplasia

This is a condition where your body stops making red blood cells. It's called 'pure' because other blood cell types, like white blood cells and platelets, are usually unaffected. This can lead to anemia (low red blood cell count).

Condition

What people with Pure Red-Cell Aplasia report

Every report comes from a Lived member, sent anonymously.

Have you tried Cyclosporine for Pure Red-Cell Aplasia?

NameHow it went

About Pure Red-Cell Aplasia

What It Is

Pure red-cell aplasia (PRCA) is a rare condition in which the bone marrow stops making red blood cells, while it usually keeps producing white blood cells and platelets normally. Red blood cells carry oxygen around the body, so when new ones stop arriving, a person gradually develops anemia (too few red blood cells). That can cause tiredness, weakness, pale skin, dizziness and shortness of breath, especially with exertion. The word "pure" is what sets PRCA apart. In aplastic anemia, a related but different condition, the marrow fails to make all three types of blood cells. In PRCA the problem is limited to the red cell line. Most cases are acquired during life and appear in adults. A separate inherited form, Diamond-Blackfan anemia, shows up in infancy or early childhood and is managed differently from the adult condition described on this page.

Causes & Risk Factors

In most acquired cases, the immune system is thought to attack the cells in the marrow that would normally mature into red blood cells. Often no underlying reason is found; this is called primary or idiopathic PRCA. In other people, PRCA develops alongside another condition, and finding it can change treatment. Recognized associations include thymoma (a tumor of the thymus gland in the chest), certain blood cancers such as large granular lymphocyte leukemia (a slow-growing cancer of immune cells), chronic lymphocytic leukemia and other B-cell disorders, autoimmune diseases such as lupus or rheumatoid arthritis, pregnancy, and stem cell transplants between donors and recipients with incompatible blood types. Parvovirus B19, the virus behind the childhood rash called fifth disease, can shut down red cell production; this is usually brief, but it can become long-lasting in people with weakened immune systems. Some medicines have been linked to PRCA, including the gout drug allopurinol, the immune suppressant azathioprine, the seizure medicines phenytoin and valproic acid, and the tuberculosis antibiotic rifampin. A rare form occurs in people treated with epoetin alfa (Epogen, Procrit, Retacrit) or similar medicines that stimulate red cell production, most often people with chronic kidney disease receiving injections under the skin, when the body makes antibodies against erythropoietin, its own red-cell-stimulating hormone. These associations do not mean a medicine or illness will cause PRCA in most people who have it.

How It's Diagnosed

PRCA is usually suspected when blood tests show anemia but normal or near-normal white cell and platelet counts. A key clue is the reticulocyte count. Reticulocytes are young red blood cells that the marrow releases every day, so a healthy marrow responding to anemia produces plenty of them. In PRCA they are nearly absent, typically below 1 percent of red cells, which points to a production problem rather than blood loss or red cells being destroyed. A bone marrow biopsy, in which a small sample of marrow is taken with a needle, confirms the diagnosis by showing that the cells that develop into red blood cells are missing or nearly missing while other cell types look normal. The marrow sample also helps rule out look-alikes such as myelodysplastic syndromes, a group of marrow disorders that can resemble PRCA. Because the cause shapes treatment, the workup then looks for associated conditions. This often includes a review of medicines, testing for parvovirus B19, a scan of the chest to look for a thymoma, tests for autoimmune disease, and blood tests that look for abnormal immune cells or abnormal antibody proteins linked to blood cancers. Nutritional deficiencies, other illnesses, and other common causes of low red cell production are ruled out along the way.

Treatment Options

Treatment has two jobs: keeping anemia safe in the short term and restoring the marrow's ability to make red cells. Red blood cell transfusions relieve symptoms and are often needed while other treatment takes effect. When a cause is found, it is addressed directly. Stopping a suspected medicine can lead to recovery. People with long-lasting parvovirus infection and a weakened immune system are usually treated with intravenous immunoglobulin (IVIG), a product made from donated antibodies that helps clear the virus. For people who develop antibodies against erythropoietin, the epoetin medicine is stopped permanently, and other medicines of the same type are avoided. For primary PRCA and most other acquired forms, the main treatment is calming the immune attack with immunosuppressive medicines. Corticosteroids such as prednisone are often the first step and help roughly half of people in published studies, though relapse is common as the dose comes down. Cyclosporine, an immunosuppressant also used after organ transplants, has the most experience behind it, with responses in about three quarters of people across observational studies, used alone or together with a steroid. It requires blood tests to check drug levels and kidney function, because it can damage the kidneys and raise blood pressure. Cyclophosphamide, sirolimus and other immune-targeted drugs are options when first treatments fail or cannot be tolerated. These figures come from case series rather than controlled trials, so they are a rough guide rather than a promise. Improvement is not immediate. Most people who respond see red cell production recover within about two to four months, although some respond sooner and some take longer. When PRCA accompanies a thymoma, the tumor is generally removed for its own sake, but surgery alone often does not cure the anemia, and many people still need immunosuppression. When it accompanies a blood cancer or autoimmune disease, treating that condition is part of the plan. A stem cell transplant is considered only rarely, for disease that does not respond to several treatments.

What to Expect

Outlook depends heavily on the cause. Anemia caused by a medicine or a short parvovirus infection may resolve completely once the trigger is removed or the infection clears. Immune-related PRCA is more often a long-term condition: many people respond well to treatment, but relapse is common when immunosuppression is reduced or stopped, and some people stay on a low maintenance dose for years. Until the marrow recovers, daily life may be shaped by fatigue and by regular blood counts and transfusions. Repeated transfusions add iron that the body cannot easily remove, so people who need many of them are monitored for iron overload, in which extra iron builds up in organs such as the liver and heart and can damage them over time. Immunosuppressive medicines lower the body's defenses, and infections are a frequent and sometimes serious problem during treatment, so care teams may recommend preventive medicines and close monitoring, particularly with stronger treatments. Long-term follow-up with a hematologist (a blood specialist) tracks blood counts, watches for relapse and checks for medicine side effects. In a small number of people, PRCA later develops into broader marrow failure, which follow-up blood counts help detect.

When to Seek Help

See a clinician if you have unexplained tiredness, pale skin or breathlessness with ordinary activity, especially if you have a condition or take a medicine linked to PRCA. If you are being treated or followed for PRCA, contact your care team promptly if symptoms of anemia return or worsen, such as increasing fatigue, dizziness or shortness of breath, since this can signal a relapse. While taking immunosuppressive medicines, a fever or other signs of infection also needs prompt contact with your care team, because infections can become serious quickly when the immune system is suppressed.

Questions to Ask Your Doctor

  1. 1.Have we found a cause for my PRCA, such as a medicine, infection, thymoma or blood disorder, and how does that change my treatment?
  2. 2.Which treatment do you recommend first, and how will we know within the first few months whether it is working?
  3. 3.How often will I need blood counts or transfusions, and should my iron levels be monitored?
  4. 4.What precautions should I take against infection while I am on immunosuppressive medicines?
  5. 5.If my anemia comes back after treatment is reduced, what would the next steps be?

Last reviewed • Oct 2026

Educational content, not medical advice.